SGLT2 Inhibitors place in therapy More than just an anti glycemic agent
SGLT2 Inhibitors place in therapy
More than just an anti glycemic agent
Schedule: December 3, 2021, 2:45 to 3:45pm Live Burlington, MA
Enduring session Release December 3, 2021 Close January 3, 2022
Audience: Accredited for Pharmacists
Other interested health care professionals welcome
Credits: 1 Contact Hour of Knowledge based
1.0 CEUs will be awarded under the provider
Presenter(s): Bridget O’Donnell, PharmD, PGY1 Pharmacy Resident, Lahey Hospital & Medical Center
No charge for CE
Learning Objectives for Pharmacists:
After attending this program, participants will be able to:
- Describe key considerations affecting SGLT2 inhibitor use such as patient selection, dosing, adverse effects and monitoring parameters
- Identify data from studies that support SGLT2 inhibitors’ expanding place in therapy for a variety of diseases
- Use knowledge of data regarding SGLT2 inhibitors to make a patient specific recommendation based on a patient case
Requirements for Receiving CE Credit:
- Successful completion of post presentation questions
- Participation at live program
- Complete program online evaluation form
- NABP #